Abstract: |
This chapter illustrates some of the instrumentation that should be familiar to surgeons performing cytoreductive surgery for advanced-stage ovarian cancer. The direct ablative technologies available today may help facilitate the goal of complete resection of all grossly visible disease and can be considered when performing these types of surgeries. Selecting appropriate patients who can tolerate an extensive cytoreductive surgery is imperative. A review of the literature reveals that all self-retaining retractors, both fixed and nonfixed, are associated with femoral nerve injury and no single retractor type has been implicated as more likely to cause injury. The electrosurgical unit consists of a generator and electrodes and is probably the most commonly used instrument in ovarian cancer surgery. The goal of surgical cytoreduction has shifted to the removal of all visible tumors. A more detailed evaluation of the histopathologic effects of electrosurgical tumor destruction of metastatic ovarian cancer by the argon beam coagulator was reported by R.E Bristow and investigators. © 2023 Taylor & Francis Group, LLC. |